6560198
Beschreibung
Karteikarten von Andrew Street, aktualisiert more than 1 year ago
|
Erstellt von Andrew Street
vor etwa 8 Jahre
|
|
| Frage | Antworten |
| Indications for venlafaxine & mirtazapine. | • Major depression - where 1st line SSRI's are ineffective/ not tolerated • Generalised anxiety disorder (venlafaxine) |
| MOA of venlafaxine & mirtazapine. | Venlafaxine is a serotonin & noradrenaline reuptake inhibitor (SNRI), interfering with uptake of these neurotransmitters from the synaptic cleft. Mirtazapine is an antagonist of inhibitory pre-synaptic α2-adrenoceptors. Both drugs increase availability of monoamines for neurotransmission, which appears to be the mechanism whereby they improve mood & physical symptoms in moderate-to-severe (but not mild) depression. Venlafaxine is a weaker antagonist of muscarinic & histamine (H1) receptors than tricyclic antidepressants, whereas mirtazapine is a potent antagonist of histamine (H1) but not muscarinic receptors. They therefore have fewer antimuscarinic side effects than tricyclic antidepressants, although mirtazapine commonly causes sedation. |
| SE's of venlafaxine & mirtazapine. | • GI upset • CNS effects (headache, abnormal dreams, insomnia, confusion, convulsions) • Hyponatraemia • Serotonin syndrome - see SSRI's • Suicidal thoughts & behaviour • Prolongs QT interval • ^Risk of ventricular arrhythmias • Sudden drug withdrawal - GI upset, neurological & flu like symptoms, sleep disturbance |
| CI's, cautions, & important interactions of venlafaxine & mirtazapine. | CI's: • None Cautions: • Elderly • Renal impairment (reduce dose) • Hepatic impairment (reduce dose) • CVD associated with inc risk of arrhythmias Important interactions: The combination of these drugs with drugs from other antidepressant classes can ^risk of adverse effects (including serotonin syndrome, see Antidepressants, selective serotonin reuptake inhibitors) & should, in general, be avoided. |
Möchten Sie mit GoConqr kostenlos Ihre eigenen Karteikarten erstellen? Mehr erfahren.